Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Profibrotic cells derived from circulating CD14+ monocytes include fibrocytes and alternatively activated macrophages. These cells are associated with interstitial lung disease (ILD) and are implicated in the pathogenesis of systemic sclerosis (SSc); however, the simultaneous presence of profibrotic cells and their associated mediators in the circulation of these patients has not been defined. We hypothesized that monocytes from patients with SSc-related ILD (SSc-ILD) would show profibrotic characteristics when compared with normal controls. We recruited patients with SSc-ILD (n=12) and normal controls (n=27) and quantified circulating collagen-producing cells by flow cytometry for CD45 and pro-collagen I. The in vitro activation potential of CD14+ monocytes in response to lipopolysaccharide was assessed using flow cytometry for CD163, and by ELISA for CCL18 and IL-10 secretion. Profibrotic mediators in plasma were quantified using Luminex-based assays. The concentration of circulating collagen-producing cells was increased in the SSc-ILD patients when compared with controls. These cells were composed of both CD34+ fibrocytes and a population of CD34+CD14+ cells. Cultured CD14+ monocytes from SSc-ILD patients revealed a profibrotic phenotype characterized by expression of CD163 and by enhanced secretion of CCL18 and IL-10 in response to proinflammatory activation. Plasma levels of IL-10, MCP-1, IL-1RA, and TNF levels were significantly elevated in the plasma of the SSc-ILD cohort. Subgroup analysis of the normal controls revealed that unlike the subjects < or =35 years, subjects > or =60 years old showed higher levels of circulating CD34+CD14+ cells, collagen-producing CD14+ monocytes, CD163+ monocytes, IL-4, IL-10, IL-13, MCP-1, and CCL18. These data indicate that the blood of patients with SSc-ILD and of healthy aged controls is enriched for fibrocytes, profibrotic monocytes, and fibrosis-associated mediators. Investigations defining the factors responsible for this peripheral blood profile may provide new insight into SSc-ILD as well as the pathophysiology of aging.
Mathai
Susan K
SK
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Gulati
Mridu
M
Peng
Xueyan
X
Russell
Thomas R
TR
Shaw
Albert C
AC
Rubinowitz
Ami N
AN
Murray
Lynne A
LA
Siner
Jonathan M
JM
Antin-Ozerkis
Danielle E
DE
Montgomery
Ruth R
RR
Reilkoff
Ronald A S
RA
Bucala
Richard J
RJ
Herzog
Erica L
EL
D000328:Adult; D002454:Cell Differentiation; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D017493:Leukocyte Common Antigens / Q000097:blood; D018950:Lipopolysaccharide Receptors / Q000097:blood; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000276:immunology / Q000473:pathology; D016676:Macrophages, Alveolar / Q000276:immunology / Q000473:pathology; D009000:Monocytes / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D011658:Pulmonary Fibrosis / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000097:blood* / Q000150:complications* / Q000276:immunology
D018950:Lipopolysaccharide Receptors; D017493:Leukocyte Common Antigens
Scand J Immunol. 1980;11(3):353-6
9537064
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17892-7
19815530
Clin Sci (Lond). 2003 Jan;104(1):27-38
12519085
PLoS One. 2009 Oct 16;4(10):e7475
19834619
Exp Dermatol. 2009 Aug;18(8):727-9
19320738
J Thorac Cardiovasc Surg. 2005 May;129(5):1144-52
15867792
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14098-103
16966615
Int J Biochem Cell Biol. 2008;40(10):2129-40
18374622
Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
16415274
Front Biosci. 2008 Jan 01;13:453-61
17981560
J Magn Reson Imaging. 2009 Dec;30(6):1284-8
19937928
Scand J Rheumatol. 2009;38(4):282-90
19255934
J Leukoc Biol. 2005 Feb;77(2):173-80
15563581
Exp Gerontol. 1999 Dec;34(8):959-70
10673149
Ann Thorac Surg. 2005 Oct;80(4):1254-60
16181849
J Allergy Clin Immunol. 2007 Feb;119(2):464-71
17291860
Arch Dermatol. 1994 May;130(5):593-7
7513987
Immun Ageing. 2009 Jul 22;6:10
19624841
Am J Respir Crit Care Med. 2007 Jul 1;176(1):70-7
17363774
J Leukoc Biol. 2008 Jun;83(6):1323-33
18332234
Mol Med. 1994 Nov;1(1):71-81
8790603
Clin Immunol. 2001 Jun;99(3):308-19
11358425
Nihon Rinsho. 2009 Mar;67(3):519-22
19280926
J Clin Invest. 2007 Mar;117(3):530-8
17332880
J Am Coll Radiol. 2008 Jan;5(1):36-9
18180007
Biochem Biophys Res Commun. 2007 Feb 2;353(1):104-8
17174272
Mol Cancer Ther. 2008 Mar;7(3):648-58
18319331
Lab Invest. 2007 Sep;87(9):858-70
17607298
Rheum Dis Clin North Am. 2003 Feb;29(1):163-84
12635506
J Immunol. 2006 Nov 15;177(10):7303-11
17082649
J Leukoc Biol. 2007 Sep;82(3):449-56
17550974
Mech Ageing Dev. 1997 Mar;94(1-3):1-5
9147355
J Immunol. 2003 Jul 1;171(1):380-9
12817021
Mech Ageing Dev. 2000 Dec 20;121(1-3):37-46
11164458
Am J Respir Crit Care Med. 2008 Sep 15;178(6):583-91
18583572
J Biol Chem. 2002 Sep 20;277(38):35466-74
12107190
Arthritis Rheum. 2007 May;56(5):1685-93
17469163
J Hepatol. 2006 Sep;45(3):429-38
16846660
J Immunol. 2001 Jun 15;166(12):7556-62
11390511
Am J Respir Crit Care Med. 2009 Apr 1;179(7):588-94
19151190
J Clin Invest. 2005 Jan;115(1):56-65
15630444
J Immunol. 2008 Apr 15;180(8):5707-19
18390756
J Immunol. 1998 Jan 1;160(1):419-25
9551999
Int J Biochem Cell Biol. 2004 Apr;36(4):598-606
15010326
J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):636-43
12865480
Ann Rheum Dis. 2007 Jul;66(7):940-4
17329309
J Immunol. 1997 Aug 1;159(3):1140-9
9233607
Nat Rev Immunol. 2005 Dec;5(12):953-64
16322748
Inflammation. 2008 Oct;31(5):299-303
18709547
Am J Respir Cell Mol Biol. 2002 May;26(5):549-57
11970906
N Engl J Med. 2006 Jun 22;354(25):2655-66
16790698